title: Reassessing artificial bowel sphincters.
abstract: The artificial sphincter has now been used for the treatment of patients with faecal incontinence since 1996. Presently, results in the UK do not match those reported from the rest of Europe, with infection caused by methicillin-resistant Staphylococcus aureus being the most common cause of failure.
authors.forename: A J
authors.initials: AJ
authors.lastname: Malouf
authors.forename: C J
authors.initials: CJ
authors.lastname: Vaizey
authors.forename: M A
authors.initials: MA
authors.lastname: Kamm
authors.forename: R J
authors.initials: RJ
authors.lastname: Nicholls
mesh_terms: D001003:Anal Canal; D001187:Artificial Organs / Q000009:adverse effects / Q000382:microbiology; D004867:Equipment Design; D004868:Equipment Failure; D005242:Fecal Incontinence / Q000601:surgery; D005500:Follow-Up Studies; D006801:Humans; D008485:Medical Audit; D016106:Methicillin Resistance; D012086:Reoperation; D018805:Sepsis / Q000145:classification; D013203:Staphylococcal Infections / Q000145:classification; D013530:Surgical Wound Infection / Q000209:etiology; D016896:Treatment Outcome